Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Clinical Trials in Beijing

A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.